Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer
Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer
Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer
Submitted by
admin
on June 1, 2017 - 9:00am
Source:
BioPharma Dive
News Tags:
Novartis
Zykadia
ALK-positive non-small cell lung cancer
Headline:
Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer
Do Not Allow Advertisers to Use My Personal information
